复合血运重建联合髂股动脉内膜剥脱术与髂动脉覆膜支架置入术治疗泛大西洋协作组C型和D型主髂动脉闭塞性疾病
回顾性分析36例(41条肢体)累及股总动脉的TASC C/D型主髂动脉闭塞患者,行髂股动脉内膜剥脱联合髂动脉覆膜支架的复合血运重建。30天死亡1例(2.7%),再手术2例(5.5%);平均随访23个月,primary patency为85.4%,累积primary assisted和secondary patency为92.6%。作者认为该术式并发症少、恢复快,覆膜支架提供良好中期通畅率,需密切无创影像随访。
要点
- 36例男性(41条肢体)TASC C/D型主髂动脉闭塞行复合血运重建,30天死亡1例(2.7%)、再手术2例(5.5%)。
- 平均随访23个月,primary patency为85.4%,累积primary assisted和secondary patency为92.6%。
- 股动脉补片修复处是最常见再干预部位(3/3),研究期间死亡34%,组织缺损者显著更高(57.1% vs 14.8%,P=0.01)。
核心结论
- 复合血运重建术并发症少、死亡率低、恢复快,覆膜支架提供良好中期通畅率,密切无创影像随访对避免修复失败至关重要,尤其是股动脉补片修复处。
研究设计与样本
- 回顾性研究,纳入累及股总动脉的TASC C和D型主髂动脉闭塞并接受复合血运重建的患者,主要使用覆膜支架。
- 共36例男性患者(41条肢体),平均年龄63.9±6岁(TASC C=39%,D=61%)。
主要发现
- 手术指征为间歇性跛行27%、静息痛44%、组织缺损29%;22%同期行辅助手术(5例腹股沟下旁路、3例股浅动脉支架)。
- 30天结局:死亡1例(2.7%),再手术2例(5.5%),其中1例因股动脉假性动脉瘤、1例因双侧腹股沟血清肿。
- 住院时间4天(四分位距3-6天);所有有数据的患者均获得30天临床和血流动力学成功。
- 平均随访23个月(范围1-79个月),primary patency为85.4%,累积primary assisted和secondary patency为92.6%;股动脉补片修复处是最常见再干预部位(3/3)。
- 研究期间死亡率为34%,组织缺损患者显著更高(57.1% vs 14.8%,P=0.01)。
临床怎么用
- 作者认为复合术式并发症少、死亡率低、恢复快,覆膜支架提供良好中期通畅率。
- 作者强调密切无创影像随访至关重要,以避免修复失败,尤其是股动脉补片修复处。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study examines the outcome of hybrid revascularization combining iliofemoral endarterectomy and iliac artery stenting using covered stents in TransAtlantic Inter-Society Consensus (TASC) C and D aortoiliac occlusive disease (AIOD) involving the common femoral artery (CFA). METHODS: A retrospective review was conducted in patients with TASC C and D AIOD involving the CFA and undergoing hybrid revascularization. Covered stents were used primarily. Demographics, indications for surgery, lesion classification, hospital length of stay (LOS), 30-day morbidity/mortality, hemodynamic and clinical success, and patency were assessed. RESULTS: Thirty-six male patients (41 limbs), mean age 63.9 ± 6 years, were identified (TASC C = 39%, D = 61%). Indications for surgery were claudication (27%), rest pain (44%), and tissue loss (29%). A simultaneous adjunctive procedure (5 infrainguinal bypass, 3 superficial femoral artery stents) was performed in 22%. Thirty-day outcomes included 1 mortality (2.7%) and 2 reoperation (5.5%), 1 for femoral artery pseudoaneurysm and 1 for bilateral groin seroma. LOS was 4 days (interquartile range 3-6). All patients with available data experienced 30-day clinical and hemodynamic success. Mean follow-up was 23 months (range 1-79 months) with a primary patency of 85.4%. Cumulative primary assisted and secondary patency was 92.6%. The femoral patch repair was the most frequent site of reintervention (3/3). Mortality was 34% during the study period, and it was significantly higher in patients with tissue loss (57.1% vs. 14.8%, P = 0.01). CONCLUSIONS: The hybrid approach has low morbidity, mortality, and fast recovery. The use of covered stents/stent grafts provides good mid-term patency. Close follow-up with noninvasive imaging is paramount to avoid repair failure, in particular at the femoral patch repair site.
引用
- Ray JJ, Eidelson SA, Karcutskie CA, et al. Hybrid Revascularization Combining Iliofemoral Endarterectomy and Iliac Stent Grafting for TransAtlantic Inter-Society Consensus C and D Aortoiliac Occlusive Disease. Ann Vasc Surg. 2018. PMID: 29481930. doi:10.1016/j.avsg.2017.11.061
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。